|
The Drug Safety and Risk Management Advisory Committee of the American Food and Drug Administration (FDA) suggests printing a warning against the risks of heart and vasuclar disease on the packaging of ADHD medicines (i.e. methylphenidate such as Ritalin and Concerta and certain amphetamines). Moreover, the Committee wants the attending doctors to hand the patients a document including guideluines about the use of those drugs.
On the one hand, the warning is based on 25 cases of heart failure, cerebral infarction and sudden death with children and adults after the use of those medicines. On the other hand, it is due to the highly increased usage of similar products in the United States, as well as by children as by adults. Almost 10% of the American boys over ten years old are said to be using an ADHD drug.
|
